• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促甲状腺激素的参考值可能不足以定义病态肥胖患者的甲状腺功能减退症:Di@bet.es 研究。

Reference values for TSH may be inadequate to define hypothyroidism in persons with morbid obesity: Di@bet.es study.

机构信息

Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.

Department of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga, IBIMA, Málaga, Spain.

出版信息

Obesity (Silver Spring). 2017 Apr;25(4):788-793. doi: 10.1002/oby.21796. Epub 2017 Mar 9.

DOI:10.1002/oby.21796
PMID:28276648
Abstract

OBJECTIVE

To analyze the reference range of thyroid-stimulating hormone (TSH) in different BMI categories and its impact on the classification of hypothyroidism.

METHODS

The study included 3,928 individuals free of thyroid disease (without previous thyroid disease, no interfering medications, TSH <10 µUI/mL and thyroid peroxidase antibodies [TPO Abs] <50 IU/mL) who participated in a national, cross-sectional, population-based study and were representative of the adult population of Spain. Data gathered included clinical and demographic characteristics, physical examination, and blood and urine sampling. TSH, free thyroxine, free triiodothyronine, and TPO Ab were analyzed by electrochemiluminescence (E170, Roche Diagnostics, Basel, Switzerland).

RESULTS

The reference range (p2.5-97.5) for TSH was estimated as 0.6 to 4.8 µUI/mL in the underweight category (BMI<20 kg/m ), 0.6 to 5.5 µUI/mL in the normal-weight category (BMI 20-24.9 kg/m ), 0.6 to 5.5 µUI/mL in the overweight category (BMI 25-29.9 kg/m ), 0.5 to 5.9 µUI/mL in the obesity category (BMI 30-39.9 kg/m ), and 0.7 to 7.5 µUI/mL in the morbid obesity category (BMI ≥40). By using the reference criteria for the normal-weight population, the prevalence of high TSH levels increased threefold in the morbid obesity category (P < 0.01).

CONCLUSIONS

Persons with morbid obesity might be inappropriately classified if the standard ranges of normality of TSH for the normal-weight population are applied to them.

摘要

目的

分析不同 BMI 类别中促甲状腺激素(TSH)的参考范围及其对甲状腺功能减退分类的影响。

方法

本研究纳入了 3928 名无甲状腺疾病(无既往甲状腺病史、无干扰药物、TSH<10µUI/mL 且甲状腺过氧化物酶抗体[TPOAb] <50IU/mL)的个体,他们参加了一项全国性的、横断面的、基于人群的研究,代表了西班牙的成年人口。收集的数据包括临床和人口统计学特征、体格检查以及血液和尿液采样。TSH、游离甲状腺素、游离三碘甲状腺原氨酸和 TPOAb 采用电化学发光法(E170,罗氏诊断公司,巴塞尔,瑞士)进行分析。

结果

在体重不足(BMI<20kg/m )类别中,TSH 的参考范围(p2.5-97.5)估计为 0.6 至 4.8µUI/mL;在正常体重(BMI 20-24.9kg/m )类别中为 0.6 至 5.5µUI/mL;在超重(BMI 25-29.9kg/m )类别中为 0.6 至 5.5µUI/mL;在肥胖(BMI 30-39.9kg/m )类别中为 0.5 至 5.9µUI/mL;在病态肥胖(BMI ≥40)类别中为 0.7 至 7.5µUI/mL。使用正常体重人群的参考标准,病态肥胖人群中高 TSH 水平的患病率增加了三倍(P<0.01)。

结论

如果将适用于正常体重人群的 TSH 正常范围标准应用于病态肥胖人群,可能会导致他们被不恰当地分类。

相似文献

1
Reference values for TSH may be inadequate to define hypothyroidism in persons with morbid obesity: Di@bet.es study.促甲状腺激素的参考值可能不足以定义病态肥胖患者的甲状腺功能减退症:Di@bet.es 研究。
Obesity (Silver Spring). 2017 Apr;25(4):788-793. doi: 10.1002/oby.21796. Epub 2017 Mar 9.
2
Raised serum TSH levels in patients with morbid obesity: is it enough to diagnose subclinical hypothyroidism?病态肥胖患者血清促甲状腺激素水平升高:这足以诊断亚临床甲状腺功能减退症吗?
Eur J Endocrinol. 2009 Mar;160(3):403-8. doi: 10.1530/EJE-08-0734. Epub 2008 Dec 10.
3
[Alterations of the thyroid function in patients with morbid obesity].[病态肥胖患者甲状腺功能的改变]
Rev Med Inst Mex Seguro Soc. 2015;53 Suppl 1:S18-22.
4
Population-Based National Prevalence of Thyroid Dysfunction in Spain and Associated Factors: Di@bet.es Study.西班牙基于人群的甲状腺功能障碍全国患病率及相关因素:Di@bet.es研究
Thyroid. 2017 Feb;27(2):156-166. doi: 10.1089/thy.2016.0353. Epub 2017 Jan 4.
5
Prevalence of subclinical hypothyroidism in a morbidly obese population and improvement after weight loss induced by Roux-en-Y gastric bypass.病态肥胖人群中亚临床甲状腺功能减退症的患病率以及 Roux-en-Y 胃旁路手术诱导体重减轻后的改善情况。
Obes Surg. 2005 Oct;15(9):1287-91. doi: 10.1381/096089205774512537.
6
[Establishment of composite reference intervals for thyroid-stimulating hormone and free thyroxine in determination of subclinical hypothyroidism].[建立促甲状腺激素和游离甲状腺素的复合参考区间用于亚临床甲状腺功能减退症的诊断]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2014 Mar;45(2):278-80.
7
Influence of obesity and surgical weight loss on thyroid hormone levels.肥胖及手术减肥对甲状腺激素水平的影响。
Surg Obes Relat Dis. 2007 Nov-Dec;3(6):631-5; discussion 635-6. doi: 10.1016/j.soard.2007.07.011.
8
Korean pediatric reference intervals for FT4, TSH, and TPO Ab and the prevalence of thyroid dysfunction: A population-based study.韩国儿童游离甲状腺素(FT4)、促甲状腺激素(TSH)和甲状腺过氧化物酶抗体(TPO Ab)的参考区间及甲状腺功能障碍患病率:一项基于人群的研究。
Clin Biochem. 2017 Dec;50(18):1256-1259. doi: 10.1016/j.clinbiochem.2017.09.024. Epub 2017 Oct 9.
9
Definition of reference ranges for free T4, TSH, and thyroglobulin levels in healthy subjects of the Jaén Health District.哈恩健康区健康受试者游离甲状腺素、促甲状腺激素和甲状腺球蛋白水平参考范围的定义。
Endocrinol Diabetes Nutr. 2017 Oct;64(8):417-423. doi: 10.1016/j.endinu.2017.06.002. Epub 2017 Jul 29.
10
Measurement of serum total thyroxine, triiodothyronine, free thyroxine, and thyrotropin concentrations for diagnosis of hypothyroidism in dogs.测定犬血清总甲状腺素、三碘甲状腺原氨酸、游离甲状腺素和促甲状腺激素浓度以诊断犬甲状腺功能减退症。
J Am Vet Med Assoc. 1997 Dec 1;211(11):1396-402.

引用本文的文献

1
Treatment of Obesity with Thyroid hormones in Europe. Data from the THESIS* Collaboration.欧洲甲状腺激素治疗肥胖症。来自THESIS*合作项目的数据。
J Endocrinol Invest. 2025 Jan;48(1):201-212. doi: 10.1007/s40618-024-02409-z. Epub 2024 Jun 15.
2
Novel reference range values for serum testosterone: a cross-sectional study of 200,000 males.血清睾酮的新型参考范围值:一项涉及 20 万名男性的横断面研究。
J Endocrinol Invest. 2024 Sep;47(9):2261-2268. doi: 10.1007/s40618-024-02319-0. Epub 2024 Feb 22.
3
Total weight loss induces the alteration in thyroid function after bariatric surgery.
体重减轻会导致减重手术后甲状腺功能的改变。
Front Endocrinol (Lausanne). 2024 Jan 30;15:1333033. doi: 10.3389/fendo.2024.1333033. eCollection 2024.
4
Subclinical Hypothyroidism in Patients with Obesity and Metabolic Syndrome: A Narrative Review.肥胖合并代谢综合征患者的亚临床甲状腺功能减退症:一篇叙述性综述。
Nutrients. 2023 Dec 27;16(1):87. doi: 10.3390/nu16010087.
5
Determination of Serum Zinc and Phosphorus Levels in Patients with Hypothyroidism.测定甲状腺功能减退症患者血清锌和磷水平。
Biol Trace Elem Res. 2024 Jul;202(7):3018-3024. doi: 10.1007/s12011-023-03905-8. Epub 2023 Oct 11.
6
Association between different metabolic phenotypes of obesity and thyroid disorders among Chinese adults: a nationwide cross-sectional study.肥胖不同代谢表型与中国成年人甲状腺疾病的关系:一项全国性横断面研究。
Front Endocrinol (Lausanne). 2023 Apr 21;14:1158013. doi: 10.3389/fendo.2023.1158013. eCollection 2023.
7
The Impact of Laparoscopic Sleeve Gastrectomy on Thyroid Functions in Egyptian Patients with Obesity.腹腔镜袖状胃切除术对埃及肥胖症患者甲状腺功能的影响。
J Gastrointest Surg. 2023 Jul;27(7):1345-1352. doi: 10.1007/s11605-023-05662-4. Epub 2023 Apr 5.
8
Levothyroxine therapy, calculated deiodinases activity and basal metabolic rate in obese or nonobese patients after total thyroidectomy for differentiated thyroid cancer, results of a retrospective observational study.左旋甲状腺素治疗、计算脱碘酶活性和基础代谢率在分化型甲状腺癌全甲状腺切除术后肥胖或非肥胖患者中的作用:一项回顾性观察研究的结果。
Endocrinol Diabetes Metab. 2023 Mar;6(2):e406. doi: 10.1002/edm2.406. Epub 2023 Feb 1.
9
Association between High Normal TSH Levels and Obesity in Women with Anti-Thyroid Autoantibodies (ATAs).抗甲状腺自身抗体(ATA)阳性女性中促甲状腺激素(TSH)水平略高于正常范围与肥胖之间的关联。
J Clin Med. 2022 Aug 31;11(17):5125. doi: 10.3390/jcm11175125.
10
Thyroid Function Alteration in Obesity and the Effect of Bariatric Surgery.肥胖症中的甲状腺功能改变及减肥手术的影响
J Clin Med. 2022 Feb 28;11(5):1340. doi: 10.3390/jcm11051340.